Dr. Anna Khimchenko

Medical science liaison at Mimosa Diagnostics
Khimchenko, Anna
SPIE Leadership: Retrieving Data, please wait...
SPIE Membership: 2.0 years
SPIE Involvement: Retrieving Data, please wait...
Websites: Company Website | Company Website | Company Website
Social Media: LinkedIn
ORCID iD: https://orcid.org/0009-0008-7611-7412
Contact Details:
Sign In to send a private message or view contact details

Profile Summary

Dr. Anna Khimchenko is an experienced diagnostic imaging scientist and science communicator with a strong background in the medical device industry. With over 10 years of international experience in commercial development, market access, and med-tech R&D, she is well-versed in driving innovation in healthcare.

Anna earned her Ph.D. in Medical Science from the University of Basel, Switzerland, focusing on tomographic imaging and brain neurodegeneration. She furthered her expertise through postdoctoral training in Dermatology at Harvard Medical School and Massachusetts General Hospital, specializing in optical coherence tomography and cystic fibrosis.

Drawing on her extensive experience in translational research and healthcare innovation, Anna has made significant contributions to fields including wounds, sepsis, antimicrobial resistance, oncology, and neurology/neurodegeneration. Her expertise and dedication make her a valuable asset in advancing medical science and improving patient care.

As a Medical Science Liaison at Mimosa Diagnostics in Toronto, Anna serves as a pivotal conduit between cutting-edge medical technology and the healthcare sector, effectively connecting innovative solutions with key stakeholders.

Upcoming Presentations

Most Recent | Show All
Retrieving Data, please wait...


Most Recent | Show All
Retrieving Data, please wait...

Conference Committee Involvement

Most Recent | Show All
Retrieving Data, please wait...

Course Instructor

Most Recent | Show All
Retrieving Data, please wait...
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research